Growth in demand for personalized medicine, surge in prevalence of chronic diseases, increase in use of metabolomics approaches in drug discovery, rise in investments in R&D activities, and advent of innovative analytical instruments and software are driving the metabolomics market growth.
Extensive study of small compounds that are referred to as metabolites, found in living organisms, biofluids, tissues, or cells is known as metabolomics.
Numerous players are currently offering innovative new-generation metabolomics solutions. As developers are constantly innovating to improve their product and service offerings, the applications of metabolomics is constantly evolving.
Furthermore, the surge in collaborations and partnerships between healthcare entities and research institutions, aimed at improving metabolomics research and mitigate associated risk factors, contributes significantly to market expansion.
Metabolomics is often considered a challenging analytical technique as, unlike genomic or proteomics, it measures molecules having disparate physical characteristics. Comprehensive metabolomics technology platforms usually adopt a unique strategy to combat this challenge.
The metabolome is often segmented into subsets of metabolites, on the basis of structural similarities such as common functional groups, or compound polarity, and then optimal protocols are devised for sample preparation and analysis of each subset.
The term metabolome is used for the analysis of these microscopic molecules and its interaction with one another inside a biological system.
Companies engaged in providing metabolomics products and services usually operate via two business models, wherein they manufacture analytical instruments as well as offer software services for metabolomics research.
The companies install their analytical instruments in research laboratories and academic institutes where scientists conduct metabolomics- based research to unveil biological discoveries.
Metabolomics is increasingly being used for drug discovery and biomarker identification. Utilizing these technological platforms, the process of translational drug discovery can be accelerated through detailed study of molecular characteristics, investigation of tumor heterogeneity, and assessment of biomarker expression in disease-affected cellular / tissue regions.
| Attribute | Detail |
|---|---|
| Drivers |
|
Personalized medicine focuses on the analysis of a patient's genetic makeup at specific locations within the genome. DNA sequence can be obtained by next-generation sequencing (NGS), which can be achieved using blood or saliva for genotyping.
Knowing a patient's genetic makeup helps doctors choose medications that are more likely to be effective rather than ones that could have unfavorable side effects. Metabolomics is employed as an impactful tool that can identify cancer biomarkers and drivers of tumorigenesis.
Over the years, metabolomics studies have been implemented to identify numerous relevant biomarkers involved in complex clinical phenotypes using diverse biological systems. Majority of the diseases result in signature metabolic profiles that reflect the sums of external and internal cellular activities.
Metabolomics play a major role in clinical practice as it represents >95% of the workload in clinical laboratories across the globe.
Furthermore, blood transcriptomics and metabolomics are being employed to generate personalized treatments because of their superior analytical skills and high accuracy. All these factors are expected to increase the metabolomics market revenue during the forecast period.
The metabolomics domain has garnered substantial funds from numerous public and private investors, due to the high return potential of such technologies. The Metabolomics Program, which is funded by a Common Fund support, establishes resources, tools, and training opportunities with an aim to increase the national capacity for using metabolomics in biomedical research.
Further, several private investors are investing in new-age metabolomics start-ups, in order to support their research and developmental demands.
For instance, Atavistik Bio raised US$ 40 million for development of its precision allosteric small molecule therapeutic in oncology, developed by utilizing the Atavistik Metabolite-Protein Screening (AMPS) technology. Thus, the surge in funding is expected to offer lucrative metabolomics market opportunities.
The metabolomics market segmentation based on product and service type includes metabolomics instruments, and bioinformatics tools and services.
Metabolomic instruments currently hold a significant metabolomics market share. Metabolomics service providers usually offer a certain portfolio of analytical tests that might not suffice the requirements of researchers; therefore, conducting metabolomics detection and screening tests for better alignment of study requirements is an important factor fueling the revenue of this segment.
According to the metabolomics industry report, based on application, the market is classified into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, personalized medicine, and others. The biomarker discovery segment dominates the market.
Metabolomics solutions are widely used for discovery of relevant biomarkers that can be implemented for diagnosis and prognosis of various disease conditions.
Numerous diagnostic biomarkers utilized for clinical decision making were identified decades before the advent of metabolomics, while after the advent of metabolomics approaches, an exponential growth in the number of known metabolites has been witnessed.
In this context, the Human Metabolite Database currently features more than 25,000 metabolites of human blood.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest metabolomics market analysis, North America held dominant share in 2023. Advancement of healthcare infrastructure, high investments in research, and augmented healthcare finances are driving market dynamics in the region.
In the U.S., several companies are launching innovative metabolomic solutions to strengthen their market position. For instance, on June 5, 2024, U.S. based company Danaher Corporation, announced the launch of SCIEX 7500+ system, a new spectrometer with improved sensitivity and resilience.
The system is equipped with Mass Guard Technology which gives it the ability to actively filter out potentially contaminating ions.
Several global metabolomics providers are based in Europe where considerable growth in market share of drug discovery research using metabolomics approaches is anticipated during the forecast period.
Over the years, there has been a notable increase in the proportion of older adults in the Asia Pacific region, rising from 4% to 10% between 1970 and 2023, and projected to reach 19% by 2050.
Expansion of the metabolomics market in Asia Pacific at the highest CAGR is ascribed to the surge in demand for novel diagnostic and prognostic approaches.
Furthermore, the metabolomics industry value in the region is anticipated to rise due to increase in instrument commercialization, rise in adoption of metabolomics research approaches, and entry of multinational firms within the marketplace.
As metabolomics providers are constantly innovating to improve product capabilities, high-throughput analytical instruments are being introduced for better workflow efficiency.
Waters Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, Metabolon, Inc., Afekta Technologies Ltd., and Shimadzu Corporation are the prominent metabolomics market players.
Each of these players has been have been profiled in the metabolomics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 2.7 Bn |
| Forecast Value in 2034 | More than US$ 9.5 Bn |
| CAGR | 12.3% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.7 Bn in 2023
It is projected to reach more than US$ 9.5 Bn by the end of 2034
The CAGR is anticipated to be 12.3% from 2024 to 2034
North America is expected to account for the largest share from 2024 to 2034
Waters Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, Metabolon, Inc., Afekta Technologies Ltd., and Shimadzu Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metabolomics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metabolomics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Recent Advancements in Metabolomics Industry
5.2. Patent Analysis
5.3. Regulatory Landscape for Venous Stents in Key Regions / Countries
5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
5.5. Impact of COVID-19 Pandemic
6. Global Metabolomics Market Analysis and Forecasts, By Product and Service Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product and Service Type, 2020-2034
6.3.1. Metabolomics Instruments
6.3.1.1. Separation Tools
6.3.1.1.1. High Performance Liquid Chromatography
6.3.1.1.2. Gas Chromatography
6.3.1.1.3. Ultra Performance Liquid Chromatography
6.3.1.1.4. Capillary Electrophoresis
6.3.1.2. Detection Tools
6.3.1.2.1. Mass Spectrometry
6.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
6.3.1.2.3. Surface-based Mass Analysis
6.3.2. Bioinformatics Tools and Services
6.3.2.1. Bioinformatics Services
6.3.2.2. Bioinformatics Tools and Databases
6.4. Market Attractiveness By Product and Service Type
7. Global Metabolomics Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Biomarker Discovery
7.3.2. Drug Discovery
7.3.3. Toxicology Testing
7.3.4. Nutrigenomics
7.3.5. Personalized Medicine
7.3.6. Others
7.4. Market Attractiveness By Application
8. Global Metabolomics Market Analysis and Forecasts, By Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Indication, 2020-2034
8.3.1. Oncological Disorders
8.3.2. Cardiovascular Disorders
8.3.3. Neurological Disorders
8.3.4. Metabolic Disorders
8.3.5. Others
8.4. Market Attractiveness By Indication
9. Global Metabolomics Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Academic and Research Institutes
9.3.2. Pharmaceutical and Biotechnology Companies
9.3.3. Contract Research Organizations
9.4. Market Attractiveness By End-user
10. Global Metabolomics Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Metabolomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product and Service Type, 2020-2034
11.2.1. Metabolomics Instruments
11.2.1.1. Separation Tools
11.2.1.1.1. High Performance Liquid Chromatography
11.2.1.1.2. Gas Chromatography
11.2.1.1.3. Ultra Performance Liquid Chromatography
11.2.1.1.4. Capillary Electrophoresis
11.2.1.2. Detection Tools
11.2.1.2.1. Mass Spectrometry
11.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
11.2.1.2.3. Surface-based Mass Analysis
11.2.2. Bioinformatics Tools and Services
11.2.2.1. Bioinformatics Services
11.2.2.2. Bioinformatics Tools and Databases
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Biomarker Discovery
11.3.2. Drug Discovery
11.3.3. Toxicology Testing
11.3.4. Nutrigenomics
11.3.5. Personalized Medicine
11.3.6. Others
11.4. Market Value Forecast By Indication, 2020-2034
11.4.1. Oncological Disorders
11.4.2. Cardiovascular Disorders
11.4.3. Neurological Disorders
11.4.4. Metabolic Disorders
11.4.5. Others
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Academic and Research Institutes
11.5.2. Pharmaceutical and Biotechnology Companies
11.5.3. Contract Research Organizations
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product and Service Type
11.7.2. By Application
11.7.3. By Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Metabolomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product and Service Type, 2020-2034
12.2.1. Metabolomics Instruments
12.2.1.1. Separation Tools
12.2.1.1.1. High Performance Liquid Chromatography
12.2.1.1.2. Gas Chromatography
12.2.1.1.3. Ultra Performance Liquid Chromatography
12.2.1.1.4. Capillary Electrophoresis
12.2.1.2. Detection Tools
12.2.1.2.1. Mass Spectrometry
12.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
12.2.1.2.3. Surface-based Mass Analysis
12.2.2. Bioinformatics Tools and Services
12.2.2.1. Bioinformatics Services
12.2.2.2. Bioinformatics Tools and Databases
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Biomarker Discovery
12.3.2. Drug Discovery
12.3.3. Toxicology Testing
12.3.4. Nutrigenomics
12.3.5. Personalized Medicine
12.3.6. Others
12.4. Market Value Forecast By Indication, 2020-2034
12.4.1. Oncological Disorders
12.4.2. Cardiovascular Disorders
12.4.3. Neurological Disorders
12.4.4. Metabolic Disorders
12.4.5. Others
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Academic and Research Institutes
12.5.2. Pharmaceutical and Biotechnology Companies
12.5.3. Contract Research Organizations
12.6. Market Value Forecast By Country / Sub-region, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product and Service Type
12.7.2. By Application
12.7.3. By Indication
12.7.4. By End-user
12.7.5. By Country / Sub-region
13. Asia Pacific Metabolomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product and Service Type, 2020-2034
13.2.1. Metabolomics Instruments
13.2.1.1. Separation Tools
13.2.1.1.1. High Performance Liquid Chromatography
13.2.1.1.2. Gas Chromatography
13.2.1.1.3. Ultra Performance Liquid Chromatography
13.2.1.1.4. Capillary Electrophoresis
13.2.1.2. Detection Tools
13.2.1.2.1. Mass Spectrometry
13.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
13.2.1.2.3. Surface-based Mass Analysis
13.2.2. Bioinformatics Tools and Services
13.2.2.1. Bioinformatics Services
13.2.2.2. Bioinformatics Tools and Databases
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Biomarker Discovery
13.3.2. Drug Discovery
13.3.3. Toxicology Testing
13.3.4. Nutrigenomics
13.3.5. Personalized Medicine
13.3.6. Others
13.4. Market Value Forecast By Indication, 2020-2034
13.4.1. Oncological Disorders
13.4.2. Cardiovascular Disorders
13.4.3. Neurological Disorders
13.4.4. Metabolic Disorders
13.4.5. Others
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Academic and Research Institutes
13.5.2. Pharmaceutical and Biotechnology Companies
13.5.3. Contract Research Organizations
13.6. Market Value Forecast By Country / Sub-region, 2020-2034
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product and Service Type
13.7.2. By Application
13.7.3. By Indication
13.7.4. By End-user
13.7.5. By Country / Sub-region
14. Latin America Metabolomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product and Service Type, 2020-2034
14.2.1. Metabolomics Instruments
14.2.1.1. Separation Tools
14.2.1.1.1. High Performance Liquid Chromatography
14.2.1.1.2. Gas Chromatography
14.2.1.1.3. Ultra Performance Liquid Chromatography
14.2.1.1.4. Capillary Electrophoresis
14.2.1.2. Detection Tools
14.2.1.2.1. Mass Spectrometry
14.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
14.2.1.2.3. Surface-based Mass Analysis
14.2.2. Bioinformatics Tools and Services
14.2.2.1. Bioinformatics Services
14.2.2.2. Bioinformatics Tools and Databases
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Biomarker Discovery
14.3.2. Drug Discovery
14.3.3. Toxicology Testing
14.3.4. Nutrigenomics
14.3.5. Personalized Medicine
14.3.6. Others
14.4. Market Value Forecast By Indication, 2020-2034
14.4.1. Oncological Disorders
14.4.2. Cardiovascular Disorders
14.4.3. Neurological Disorders
14.4.4. Metabolic Disorders
14.4.5. Others
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Academic and Research Institutes
14.5.2. Pharmaceutical and Biotechnology Companies
14.5.3. Contract Research Organizations
14.6. Market Value Forecast By Country / Sub-region, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product and Service Type
14.7.2. By Application
14.7.3. By Indication
14.7.4. By End-user
14.7.5. By Country / Sub-region
15. Middle East & Africa Metabolomics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product and Service Type, 2020-2034
15.2.1. Metabolomics Instruments
15.2.1.1. Separation Tools
15.2.1.1.1. High Performance Liquid Chromatography
15.2.1.1.2. Gas Chromatography
15.2.1.1.3. Ultra Performance Liquid Chromatography
15.2.1.1.4. Capillary Electrophoresis
15.2.1.2. Detection Tools
15.2.1.2.1. Mass Spectrometry
15.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
15.2.1.2.3. Surface-based Mass Analysis
15.2.2. Bioinformatics Tools and Services
15.2.2.1. Bioinformatics Services
15.2.2.2. Bioinformatics Tools and Databases
15.3. Market Value Forecast By Application, 2020-2034
15.3.1. Biomarker Discovery
15.3.2. Drug Discovery
15.3.3. Toxicology Testing
15.3.4. Nutrigenomics
15.3.5. Personalized Medicine
15.3.6. Others
15.4. Market Value Forecast By Indication, 2020-2034
15.4.1. Oncological Disorders
15.4.2. Cardiovascular Disorders
15.4.3. Neurological Disorders
15.4.4. Metabolic Disorders
15.4.5. Others
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Academic and Research Institutes
15.5.2. Pharmaceutical and Biotechnology Companies
15.5.3. Contract Research Organizations
15.6. Market Value Forecast By Country / Sub-region, 2020-2034
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product and Service Type
15.7.2. By Application
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country / Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Waters Corporation
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Agilent Technologies, Inc.
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. Thermo Fisher Scientific Inc.
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. Danaher Corporation
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. Bruker Corporation
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. PerkinElmer
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. Merck KGaA
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments
16.2.8. Metabolon, Inc.
16.2.8.1. Company Overview
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Business Strategies
16.2.8.5. Recent Developments
16.2.9. Afekta Technologies Ltd.
16.2.9.1. Company Overview
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Business Strategies
16.2.9.5. Recent Developments
16.2.10. Shimadzu Corporation
16.2.10.1. Company Overview
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Business Strategies
16.2.10.5. Recent Developments
List of Tables
Table 01: Global Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
Table 02: Global Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instrument, 2020-2034
Table 03: Global Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 04: Global Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 05: Global Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 06: Global Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 07: Global Metabolomics Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 08: North America Metabolomics Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 09: North America Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
Table 10: North America Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instrument, 2020-2034
Table 11: North America Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 12: North America Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 13: North America Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 14: North America Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 15: Europe Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Europe Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
Table 17: Europe Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
Table 18: Europe Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 19: Europe Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Europe Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 21: Europe Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 22: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 23: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
Table 24: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
Table 25: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 26: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 27: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 28: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 29: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 30: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
Table 31: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
Table 32: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 33: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 34: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 35: Latin America Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 36: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 37: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 38: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
Table 39: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
Table 40: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 41: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 42: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Metabolomics Market Value (US$ Mn) Forecast, 2020-2034
Figure 02: Global Metabolomics Market Value Share, by Product and Service Type, 2023
Figure 03: Global Metabolomics Market Value Share, by Application, 2023
Figure 04: Global Metabolomics Market Value Share, by Indication, 2023
Figure 05: Global Metabolomics Market Value Share, by End-user, 2023
Figure 06: Global Metabolomics Market Value Share, by Region, 2023
Figure 07: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 08: Global Metabolomics Market Share Analysis, by Product and Service Type, 2023
Figure 09: Global Metabolomics Market Share Analysis, by Product and Service Type, 2034
Figure 10: Global Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 11: Global Metabolomics Market Value (US$ Mn), by Metabolomic Instruments, 2020-2034
Figure 12: Global Metabolomics Market Value Share Analysis, by Metabolomic Instruments, 2023 and 2034
Figure 13: Global Metabolomics Market Value (US$ Mn), by Bioinformatics Tools and Services, 2020-2034
Figure 14: Global Metabolomics Market Value Share Analysis, by Bioinformatics Tools and Services, 2023 and 2034
Figure 15: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 16: Global Metabolomics Market Share Analysis, by Application, 2023
Figure 17: Global Metabolomics Market Share Analysis, by Application, 2034
Figure 18: Global Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 19: Global Metabolomics Market Value (US$ Mn), by Biomarker Discovery, 2020-2034
Figure 20: Global Metabolomics Market Value Share Analysis, by Biomarker Discovery, 2023 and 2034
Figure 21: Global Metabolomics Market Value (US$ Mn), by Drug Discovery, 2020-2034
Figure 22: Global Metabolomics Market Value Share Analysis, by Drug Discovery, 2023 and 2034
Figure 23: Global Metabolomics Market Value (US$ Mn), by Toxicology Testing, 2020-2034
Figure 24: Global Metabolomics Market Value Share Analysis, by Toxicology Testing, 2023 and 2034
Figure 25: Global Metabolomics Market Value (US$ Mn), by Nutrigenomics, 2020-2034
Figure 26: Global Metabolomics Market Value Share Analysis, by Nutrigenomics, 2023 and 2034
Figure 27: Global Metabolomics Market Value (US$ Mn), by Personalized Medicine, 2020-2034
Figure 28: Global Metabolomics Market Value Share Analysis, by Personalized Medicine, 2023 and 2034
Figure 29: Global Metabolomics Market Value (US$ Mn), by Others, 2020-2034
Figure 30: Global Metabolomics Market Value Share Analysis, by Others, 2023 and 2034
Figure 31: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 32: Global Metabolomics Market Share Analysis, by Indication, 2023
Figure 33: Global Metabolomics Market Share Analysis, by Indication, 2034
Figure 34: Global Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 35: Global Metabolomics Market Value (US$ Mn), by Oncological Disorders, 2020-2034
Figure 36: Global Metabolomics Market Value Share Analysis, by Oncological Disorders, 2023 and 2034
Figure 37: Global Metabolomics Market Value (US$ Mn), by Cardiovascular Disorders, 2020-2034
Figure 38: Global Metabolomics Market Value Share Analysis, by Cardiovascular Disorders, 2023 and 2034
Figure 39: Global Metabolomics Market Value (US$ Mn), by Neurological Disorders, 2020-2034
Figure 40: Global Metabolomics Market Value Share Analysis, by Neurological Disorders, 2023 and 2034
Figure 41: Global Metabolomics Market Value (US$ Mn), by Metabolic Disorders, 2020-2034
Figure 42: Global Metabolomics Market Value Share Analysis, by Metabolic Disorders, 2023 and 2034
Figure 43: Global Metabolomics Market Value (US$ Mn), by Others, 2020-2034
Figure 44: Global Metabolomics Market Value Share Analysis, by Others, 2023 and 2034
Figure 45: Global Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 46: Global Metabolomics Market Share Analysis, by End-user, 2023
Figure 47: Global Metabolomics Market Share Analysis, by End-user, 2034
Figure 48: Global Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 49: Global Metabolomics Market Value (US$ Mn), by Academic and Research Institutes, 2020-2034
Figure 50: Global Metabolomics Market Value Share Analysis, by Academic and Research Institutes, 2023 and 2034
Figure 51: Global Metabolomics Market Value (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020-2034
Figure 52: Global Metabolomics Market Value Share Analysis, by Pharmaceutical and Biotechnology Companies, 2023 and 2034
Figure 53: Global Metabolomics Market Value (US$ Mn), by Contract Research Organizations, 2020-2034
Figure 54: Global Metabolomics Market Value Share Analysis, by Contract Research Organizations, 2023 and 2034
Figure 55: Global Metabolomics Market Value Share Analysis, by Region, 2023 and 2034
Figure 56: Global Metabolomics Market Share Analysis, by Region, 2023
Figure 57: Global Metabolomics Market Share Analysis, by Region, 2034
Figure 58: Global Metabolomics Market Attractiveness Analysis, by Region, 2023-2034
Figure 59: North America Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 60: North America Metabolomics Market Value Share Analysis, by Country, 2023 and 2034
Figure 61: North America Metabolomics Market Attractiveness Analysis, by Country, 2024-2034
Figure 62: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 63: North America Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 64: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 65: North America Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 66: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 67: North America Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 68: North America Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 69: North America Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 70: Europe Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 71: Europe Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 72: Europe Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 73: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 74: Europe Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 75: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 76: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 77: Europe Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 78: Europe Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 79: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 80: Europe Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 81: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 82: Asia Pacific Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 83: Asia Pacific Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 84: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 85: Asia Pacific Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 86: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 87: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 88: Asia Pacific Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 89: Asia Pacific Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 90: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 91: Asia Pacific Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 92: Latin America Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 93: Latin America Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 94: Latin America Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 95: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 96: Latin America Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 97: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 98: Latin America Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 99: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 100: Latin America Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 101: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 102: Latin America Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 103: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 104: Middle East & Africa Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 105: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 106: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
Figure 107: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
Figure 108: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 109: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
Figure 110: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 111: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
Figure 112: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 113: Middle East & Africa Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Metabolomics Market
